Serological prevalence of SARS-CoV-2 antibody among children and young age group (between 2 and 17 years) in India: An interim result from a large multicentric population-based seroepidemiological study

BACKGROUND: Estimating seroepidemiolgical prevalence of SARS-CoV-2 antibody is an essential public health strategy. There is insufficient evidence of prevalence among those belonging to young age population in India. OBJECTIVE: To compare the SARS-CoV-2 seropositivity rate between children and adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Misra, Puneet, Kant, Shashi, Guleria, Randeep, Rai, Sanjay K., Kishore, Surekha, Baidya, Subrata, Singh, Arvind Kumar, Chinnakali, Palanivel, Medigeshi, Guruprasad R., Chaturvedi, Pradeep Kumar, Joshi, Hari Shanker, Mandal, Suprakash, Sangral, Meenu, Yadav, Kapil, Bairwa, Mohan, Haldar, Partha, Kardam, Priyanka, Patil, Sharanabasava, Jha, Shreya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480647/
https://www.ncbi.nlm.nih.gov/pubmed/36119298
http://dx.doi.org/10.4103/jfmpc.jfmpc_2274_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480647/
https://www.ncbi.nlm.nih.gov/pubmed/36119298
http://dx.doi.org/10.4103/jfmpc.jfmpc_2274_21

Ejemplares similares